Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,005 public trials 1,840 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Study of Enzastaurin in Participants With Follicular Lymphoma

NCT00475644

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Casa Grande, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Verne, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

NCT01133158

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain
  • Hospital Txagorritxu Vitoria-Gasteiz, Alava, Spain
  • Hospital San Juan de Alicante Sant Joan d'Alacant, Alicante, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 41 locations
View Trial Details
Completed

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

NCT01965119

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • Busan University Hospital Busan, South Korea
  • Dong-A University Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Completed

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

NCT00641095

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia
  • William Harvey Hospital Ashford, England, United Kingdom
  • Stoke Mandeville Hospital Aylesbury, England, United Kingdom
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
View all 67 locations
View Trial Details
Completed

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00963105

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
View all 52 locations
View Trial Details

Related conditions